Peptonic Medical launches VagiVital V cleanser
Stockholm, March 31, 2021 - Peptonic Medical AB (publ) (‘Peptonic’ or ‘the Company’) today announces the launch of a in-house developed intimate wash - VagiVital V cleanser - which is both gentle and moisturizing.
The cleanser is a unique combination of VagiVital's carefully researched vaginal gel (for the treatment of dry mucous membranes in the vagina) and mild Swedish rapeseed oil. It is emollient, pH-balancing and completely free of soaps, perfume and parabens. VagiVital V cleanser is suitable for women of all ages and can be combined with VagiVital Active Gel for good intimate health.
- We are proud to launch another product that promotes female intimate health. Our V cleanser is an excellent complement to VagiVital Aktivgel, which has a clinically proven effect against dry mucous membranes. VagiVital V cleanser provides gentle cleansing of sensitive intimate areas, says Johan Inborr, CEO of Peptonic Medical, the company behind VagiVital.
VagiVital V cleanser has been evaluated in a test group before the launch. As many as 95% of the test group members felt a clear moisturizing effect after use for 14 days and just as many (95%) would recommend the product to a friend.
- A cleanser with moisturizing properties has been lacking on the market and we see that there is a great demand. It makes me both proud and happy that we can now offer an in-house developed cleanser to meet this demand, says Nikolina Spolén, product manager at Peptonic Medical.
VagiVital V cleanser is available for purchase at www.vagivital.se for SEK 129.
For more information, please contact;
Johan Inborr, CEO
Mobile: +46 708 853 893
This information is information that Peptonic Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 31st March 2021.
About Peptonic Medical AB
Peptonic Medical AB (publ) is an innovative biomedical company that conducts research on and development of drugs and medical devices in the field of women's health. Our vision is to offer safe and effective treatments for women-specific diseases and medical conditions. Peptonic Medical launched VagiVital® in July 2018. This is a hormone-free product for the treatment of vaginal atrophy and vaginal dryness. The company's development program also includes Vagitocin® - a product that contains oxytocin for the treatment of vaginal atrophy. The development of Vagitocin® has been put on hold pending new information regarding the mechanism of action of oxytocin in this indication. The company was founded in 2009 and the share has been traded since 2014 on Spotlight (www.spotlightstockmarket.se, short code: PMED) in Stockholm.
Since August 2020, Lune Group Oy Ltd. is a wholly owned subsidiary of the Peptonic Medical. Lune Group Oy Ltd. is a company founded by Heli Kurjanen in 2005. The company's business concept is to lead a menstrual revolution in a positive spirit. By focusing on sustainable development, environmental issues and the promotion of sexual health, the company has developed to take the lead for the menopausal companies. Lunette® menstrual cups are an alternative to disposable menstrual protection and last for several years. The company has resellers in 50 countries and sells Lunette products to over 100 countries via its web shop. Lune Group has in the USA the subsidiary Lune North America Inc. Lunette® menstrual cups are designed, manufactured and packaged in Finland. For more information about Lunette®, visit www.lunette.com.